Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Albizia adianthifolia extract refers to any preparation obtained from the heartwood, bark, leaves, or roots of the plant Albizia adianthifolia, a tree used extensively in African traditional medicine. Extracts contain a broad array of phytochemicals such as apocarotenoids, chalcones, dipeptides, elliptosides, essential oils, fatty acids, flavonoids, histamine, imidazolyl carboxylic acid, prosapogenins, steroids, triterpene saponins, and triterpenoids. Preclinical studies suggest numerous bioactivities, including antibacterial, antifungal, antioxidant, anti-inflammatory, anxiolytic, antidepressant, cognitive-enhancing, hypoglycemic, immunomodulatory, acetylcholinesterase inhibitory, cytotoxic, and other effects. Major compounds identified in extracts include n-hexadecanoic acid, oleic acid, chondrillasterol, stigmasterol, 24S 5α-stigmast-7-en-3β-ol, 9,12-octadecadienoic acid (Z,Z)-, methyl ester, and trans-13-octadecenoic acid, methyl ester. There is no established pharmaceutical use or approval, and clinical studies are lacking. Uses are limited to traditional medicine as a herbal remedy for diabetes, gastrointestinal and neurological disorders, skin diseases, and infections[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on albizia adianthifolia extract.